Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CDC20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ITGAE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UTP11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPSM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AIMP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADH5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM185B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RUVBL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC27A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARRB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNAS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP2U1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATAD3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
XRCC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARNTL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VTI1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHF19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUP88 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on